Clinical Trial Update: Irbesartan in Hypertension [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial of irbesartan for hypertension, with the study status listed as completed. The sponsor is Sanofi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AVAPRO (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED